Synaptogenix Embarks on AI-Focused Cryptocurrency Strategy with TAO Purchase

According to Foresight News, biopharmaceutical company Synaptogenix (NASDAQ: SNPX) has announced its initial acquisition of TAO, although the specific purchase amount remains undisclosed. This move is part of the company's recently unveiled financial strategy centered on artificial intelligence (AI) and machine learning. Synaptogenix has selected BitGo to provide qualified custody, staking, and trading services for its TAO assets.